Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
October 06, 2024
From CNBC.com News
From CNBC.com News
Five things: Industrious, hotel workers strike, biotech layoffs, and an adorable way to start the day
October 02, 2024
From Business Journals
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
From CNBC.com News
23andMe's Anne Wojcicki now says her take-private plan is the best option for company
October 01, 2024
From Business Journals
CVS is working with advisors on strategic review, sources say
September 30, 2024
From CNBC.com News
Major CVS shareholder plans activist push, will meet with management, sources say
September 29, 2024
From CNBC.com News
BioAge seeks nearly $200 million in initial public offering
September 27, 2024
From Business Journals
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
From Benzinga
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
From Benzinga
From CNBC.com News
Commentary: Congress has just weeks to help children with rare diseases
September 20, 2024
From Business Journals
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
From Benzinga
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
September 14, 2024
From CNBC.com News
Biotech raises $315 million in IPO, surpassing $250M target
September 13, 2024
From Business Journals
Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look'
September 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.